Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 7.47
(-0.53%)
CNY 7.47
(-0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 644.97 Million | 549.53 Million | 629.76 Million | 358.23 Million | 515.95 Million | 607.43 Million |
| Cost of Revenue | 283.93 Million | 227.89 Million | 224.66 Million | 184.22 Million | 174.13 Million | 169.35 Million |
| Gross Profit | 361.03 Million | 321.64 Million | 405.09 Million | 174 Million | 341.81 Million | 438.07 Million |
| Operating Expenses | 334.81 Million | 274.43 Million | 357.85 Million | 266.65 Million | 333.51 Million | 395.89 Million |
| Selling, General and Administrative Expenses | 265.53 Million | 170.19 Million | 201.71 Million | 207.54 Million | 292.99 Million | 344.14 Million |
| Research and Development Expenses | 64.44 Million | 59.61 Million | 102.21 Million | 27.8 Million | 26.98 Million | 26.56 Million |
| Other Expenses | 4.82 Million | 44.62 Million | 53.93 Million | 31.31 Million | 13.53 Million | 18.71 Million |
| Cost and Expenses | 622.93 Million | 502.32 Million | 582.52 Million | 450.87 Million | 507.65 Million | 565.25 Million |
| Operating Income | 22.03 Million | 56.8 Million | 54.92 Million | 28.78 Million | 46.29 Million | -130.26 Million |
| Interest Expense | 2.6 Million | 1.64 Million | 2.11 Million | 188.53 Thousand | 34.03 Thousand | 1.18 Million |
| Income Tax Expense | 7.97 Million | 9.26 Million | 13.21 Million | 2.86 Million | 8.92 Million | 14.92 Million |
| Earnings before Tax | 33.07 Million | 55.19 Million | 48.87 Million | -176.5 Million | 16.78 Million | -111.54 Million |
| Net Income | 25.4 Million | 44.75 Million | 35.65 Million | -179.36 Million | 7.85 Million | -126.47 Million |
| Earnings Per Share Basic | 0.07 | 0.14 | 0.11 | -0.56 | 0.02 | -0.39 |
| Earnings Per Share Diluted | 0.07 | 0.14 | 0.11 | -0.56 | 0.02 | -0.39 |
| Weighted Average Shares Outstanding | 362.96 Million | 328.12 Million | 322.59 Million | 322.59 Million | 322.59 Million | 322.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 362.96 Million | 328.12 Million | 322.59 Million | 322.59 Million | 322.59 Million | 324.29 Million |
| Gross Margin | 0.56 | 0.59 | 0.64 | 0.49 | 0.66 | 0.72 |
| EBIT Margin | 0.17 | 0.22 | 0.17 | 0.26 | 0.20 | 0.47 |
| Profit Margin | 0.04 | 0.08 | 0.06 | -0.50 | 0.02 | -0.21 |
| EBITDA | 111.25 Million | 127.03 Million | 114.16 Million | 117.83 Thousand | 64.39 Million | 94.88 Million |
| Earnings Before Tax Margin | 0.03 | 0.10 | 0.09 | 0.08 | 0.09 | -0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 120.85 Million | 99.01 Million | 137.83 Million | 146.17 Million | 644.97 Million | 157.23 Million |
| Cost of Revenue | 64.4 Million | 47.89 Million | 67.08 Million | 64.09 Million | 283.93 Million | 73.17 Million |
| Gross Profit | 56.44 Million | 51.12 Million | 70.75 Million | 82.08 Million | 361.03 Million | 84.06 Million |
| Operating Expenses | 76.06 Million | 73.83 Million | 65.27 Million | 118.41 Million | 341.33 Million | 89.98 Million |
| Selling, General and Administrative Expenses | 67.54 Million | 26.03 Million | 52.38 Million | 58.75 Million | - | 86.23 Million |
| Research and Development Expenses | 9.18 Million | 23.44 Million | 12.12 Million | 13.6 Million | - | 22.5 Million |
| Other Expenses | -8.51 Million | -1.77 Million | -176.02 Thousand | -1.07 Million | 11.03 Million | -76.4 Thousand |
| Cost and Expenses | 140.47 Million | 121.73 Million | 132.35 Million | 182.5 Million | 625.26 Million | 163.16 Million |
| Operating Income | -19.61 Million | -25.42 Million | 6.01 Million | -52.74 Million | 22.03 Million | 7.02 Million |
| Interest Expense | 2.3 Million | 2.54 Million | 1.2 Million | - | 2.6 Million | - |
| Income Tax Expense | 1.25 Million | 2.56 Million | 1.59 Million | 274.89 Thousand | 7.97 Million | 898.52 Thousand |
| Earnings before Tax | -1.72 Million | -26.5 Million | 5.84 Million | -53.81 Million | 33.07 Million | 6.94 Million |
| Net Income | -6.03 Million | -29.01 Million | 4.29 Million | -54.03 Million | 25.4 Million | 6.09 Million |
| Earnings Per Share Basic | -0.02 | -0.07 | 0.01 | -0.17 | - | 0.02 |
| Earnings Per Share Diluted | -0.02 | -0.07 | 0.01 | -0.17 | - | 0.02 |
| Weighted Average Shares Outstanding | 369.27 Million | 429.65 Million | 429.65 Million | 316.92 Million | 362.96 Million | 379.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 369.27 Million | 429.65 Million | 429.65 Million | 316.92 Million | 362.96 Million | 379.06 Million |
| Gross Margin | 0.47 | 0.52 | 0.51 | 0.56 | 0.56 | 0.53 |
| EBIT Margin | 0.00 | -0.21 | 0.04 | -0.04 | - | -0.04 |
| Profit Margin | -0.05 | -0.29 | 0.03 | -0.37 | 0.04 | 0.04 |
| EBITDA | 572.05 Thousand | -21.02 Million | 6.19 Million | -6.28 Million | - | -6.28 Million |
| Earnings Before Tax Margin | -0.16 | -0.26 | 0.04 | -0.36 | 0.03 | 0.04 |
603183
6505
7279
6738
WIRTEK
YGRAF